Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1138723 · FYE Jun 30 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $0.24Day +8.18%Mkt cap $29M1Y −82.5%Off 52W high −88.4%Vol (1Y) 100.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 4,894 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.0% of sh out |
| Days to cover3.4d |
| 13F net flow (QoQ)+0.06% |
| Top-10 13F concentration71.3% |
| Next report (est.)2026-08-05 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$428.6M |
| Earnings (TTM)-$46.1M |
| ROE−2.5% |
| Net margin−0.3% |
| ROIC0.0% |
| Debt / equity1.68× |
| Total debt / EBITDA9.76× |
| Sales growth 3Y2.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−70.3% |
| 1Y−82.5% |
| 3Y−94.2% |
| 5Y−94.1% |
| 10Y−95.6% |
| Since incept. (ann.)−21.7% |
Total return through 2026-07-28 · series begins 2007-02-08. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)100.7% |
| Ann. volatility (3Y)84.1% |
| Sharpe (1Y)−1.23 |
| Sharpe (3Y)−0.70 |
| Max drawdown (1Y)−87.8% |
| Max drawdown (3Y)−94.7% |
| Beta (3Y vs SPY)2.06 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| TCW GROUP INC | 15.5M | $4M | 13.00% | +0.0% |
| BlackRock, Inc. | 8.5M | $3M | 7.11% | −1.0% |
| NEUBERGER BERMAN GROUP LLC | 5.9M | $2M | 4.92% | +17.9% |
| ARMISTICE CAPITAL, LLC | 5.6M | $2M | 4.74% | +25.2% |
| WEBER CAPITAL MANAGEMENT LLC /ADV | 5.1M | $2M | 4.25% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | $2M | 3.72% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $924,159 | 2.00% | −3.9% |
| MACKENZIE FINANCIAL CORP | 2.3M | $910,622 | 1.97% | +22.3% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-06 | — | — | $104.8M | −7.4% |
| 2025-12-31 | 2026-02-04 | −$0.11 | −650.0% | $102.2M | −12.0% |
| 2025-09-30 | 2025-11-05 | −$0.18 | — | $93.9M | −7.5% |
| 2025-06-30 | 2025-08-13 | — | — | $127.5M | −5.0% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-05 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Europe India Middle East And Africa 31% · CN 27% · Americas 19% · JP 12% · Asia Pacific 10%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
